Novo Nordisk | NVO - Current Assets

Stock Price
50.30
Daily Change
-8.71 -14.76%
Monthly
-8.81%
Yearly
-39.15%
Q1 Forecast
56.42

Novo Nordisk reported DKK25.71B in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
ANI Pharmaceuticals USD 698.4M 95.77M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Bausch Health Companies USD 6.25B 265M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novo Nordisk DKK 181.88B 19.18B Sep/2025
Novo Nordisk DKK 25.71B 148.69B Jun/2025
Pacira USD 562.75M 182.86M Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Prestige Brands USD 497.41M 16.89M Sep/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025
Zoetis USD 6.58B 660M Sep/2025